XM does not provide services to residents of the United States of America.

First Airbus A321XLR delivery due in second-half October, airline says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-First Airbus A321XLR delivery due in second-half October, airline says</title></head><body>

Adds context and details from paragraph 3

Sept 20 (Reuters) -The first delivery of Airbus' AIR.PA longest-range narrowbody jet, the A321XLR, is poised to slip into October, apparently missing the planemaker's delivery target by several weeks.

A spokesperson for Spain's Iberia ICAG.L said in response to a Reuters query that the delivery is planned for the second half of October.

Airbus referred questions on the delivery to the airline. In July, it said it expected the A321XLR to be delivered "at the end of the summer," having previously cited the third quarter.

The delivery from Hamburg represents a milestone in a fierce competition between Airbus and Boeing BA.N to meet demand to serve longer routes with workhorse narrowbody jets.

The A321XLR was launched in 2019 with an initial target for entry to service of 2023 to help airlines open new routes without the need to fill up larger wide-body aircraft. Boeing is developing a larger version of its 737 family, the MAX 10.

The debut A321XLR delivery was originally earmarked for Iberia's sister airline Aer Lingus but was switched to the Spanish network by parent group IAG ICAG.L earlier this year amid uncertainty during a recent Aer Lingus pilots' strike.

The uncertainty spilled into the paint shops with one aircraft seen recently in Aer Lingus colours but with an Iberia logo on the engine cover during testing, according to industry publication the Irish Air Letter, which expects Aer Lingus to receive two of the long-distance planes in the fourth quarter.

Airbus said it had sold more than 500 of the recently certified A321XLR model but did not give a breakdown by airline.

IAG did not immediately respond to a request for comment.



Reporting by Tim Hepher, Belén Carreño, Joanna Plucinska, Editing by Louise Heavens

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.